These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 8399909

  • 1. Immunomodulation in vivo by the Mycoplasma arthritidis superantigen, MAM.
    Cole BC, Ahmed E, Araneo BA, Shelby J, Kamerath C, Wei S, McCall S, Atkin CL.
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S163-9. PubMed ID: 8399909
    [Abstract] [Full Text] [Related]

  • 2. Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM.
    Cole BC, Sawitzke AD, Ahmed EA, Atkin CL, David CS.
    Infect Immun; 1997 Oct; 65(10):4190-8. PubMed ID: 9317026
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Mycoplasma arthritidis superantigen MAM: purification and identification of an active peptide.
    Atkin CL, Wei S, Cole BC.
    Infect Immun; 1994 Dec; 62(12):5367-75. PubMed ID: 7960116
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM.
    Cole BC, Griffiths MM.
    Arthritis Rheum; 1993 Jul; 36(7):994-1002. PubMed ID: 8318046
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen.
    Cole BC, Atkin CL.
    Immunol Today; 1991 Aug; 12(8):271-6. PubMed ID: 1910449
    [Abstract] [Full Text] [Related]

  • 12. Interaction of Mycoplasma arthritidis superantigen with human T cells.
    Posnett DN, Hodtsev AS, Kabak S, Friedman SM, Cole BC, Bhardwaj N.
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S170-5. PubMed ID: 8399910
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM): generation of a monoclonal antibody against V beta 17, the T cell receptor gene product expressed by a large fraction of MAM-reactive human T cells.
    Friedman SM, Crow MK, Tumang JR, Tumang M, Xu YQ, Hodtsev AS, Cole BC, Posnett DN.
    J Exp Med; 1991 Oct 01; 174(4):891-900. PubMed ID: 1833503
    [Abstract] [Full Text] [Related]

  • 16. Genomic composition and allelic polymorphisms influence V beta usage by the Mycoplasma arthritidis superantigen.
    Cole BC, Balderas RA, Ahmed EA, Kono D, Theofilopoulos AN.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3291-9. PubMed ID: 8468471
    [Abstract] [Full Text] [Related]

  • 17. TLR2 and TLR4 differentially regulate B7-1 resulting in distinct cytokine responses to the mycoplasma superantigen MAM as well as to disease induced by Mycoplasma arthritidis.
    Mu HH, Humphreys J, Chan FV, Cole BC.
    Cell Microbiol; 2006 Mar 15; 8(3):414-26. PubMed ID: 16469054
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The immunobiology of Mycoplasma arthritidis and its superantigen MAM.
    Cole BC.
    Curr Top Microbiol Immunol; 1991 Mar 15; 174():107-19. PubMed ID: 1802617
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.